Shocked! Nearly 9 billion R & D investment from 10 pharmaceutical companies
-
Last Update: 2018-05-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: minenet 2018-05-08, the annual report of Listed Companies in 2017 has been disclosed For the pharmaceutical industry, R & D investment has always been one of the most eye-catching focuses According to statistics, there are 10 A-share pharmaceutical companies with R & D investment of more than 500 million yuan, among which Hengrui pharmaceutical and Fosun Pharmaceutical have exceeded 1.5 billion yuan; only Hengrui pharmaceutical has R & D investment accounting for more than 10% of revenue, while Fosun Pharmaceutical, Kelun pharmaceutical and Haizheng pharmaceutical have exceeded 7%.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
